Ossifying fibroma (OF) is a fibro-osseous tumor that usually occurs in young people and arises in the craniofacial bones. We report a case of a 15-year-old boy who developed progressive proptosis and hypertelorism and was found to have a mid-face and skull base tumor, initially diagnosed as psammomatoid meningioma. The tumor recurred and the resected specimen revealed a unique OF having trabecular and psammomatoid features. The clinical, radiographic, histopathologic findings and differential diagnoses of the case are presented.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037469PMC
http://dx.doi.org/10.1007/s12105-010-0212-4DOI Listing

Publication Analysis

Top Keywords

trabecular psammomatoid
8
ossifying fibroma
8
skull base
8
psammomatoid meningioma
8
psammomatoid juvenile
4
juvenile ossifying
4
fibroma skull
4
base mimicking
4
mimicking psammomatoid
4
meningioma ossifying
4

Similar Publications

Classification of Fibro-osseous Tumors in the Craniofacial Bones using DNA Methylation and Copy Number Alterations.

Mod Pathol

January 2025

Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, the Netherlands; Department of Pathology, Amsterdam University Medical Center, Amsterdam, the Netherlands. Electronic address:

Fibro-osseous tumors of the craniofacial bones are a heterogeneous group of lesions comprising cemento-osseous dysplasia (COD), cemento-ossifying fibroma (COF), juvenile trabecular ossifying fibroma (JTOF), psammomatoid ossifying fibroma (PsOF), fibrous dysplasia (FD), and low-grade osteosarcoma (LGOS) with overlapping clinicopathological features. However, their clinical behavior and treatment differ significantly, underlining the need for accurate diagnosis. Molecular diagnostic markers exist for subsets of these tumors, including GNAS mutations in FD, SATB2 fusions in PsOF, mutations involving the RAS-MAPK signaling pathway in COD, and MDM2 amplification in LGOS.

View Article and Find Full Text PDF

Objective: To assess the sclerostin, β-catenin, and tryptase expression in fibro-osseous lesions (FOL) of the jaws.

Subjects And Methods: Immunohistochemistry analysis was performed for these proteins on FOL and non-lesional bone. The sclerostin-positive cells were scored from 0 (no expression) to 3 (high expression).

View Article and Find Full Text PDF

Ossifying fibroma and juvenile ossifying fibroma: A systematic review on clinical and radiological parameters, treatment modalities and recurrence.

J Stomatol Oral Maxillofac Surg

December 2024

Nantes Université, CHU Nantes, Service de Chirurgie Maxillo-Faciale et Stomatologie, F-44000, Nantes, France; Nantes Université, Univ Angers, CHU Nantes, INSERM, CNRS, CRCI2NA, F-44000, Nantes, France. Electronic address:

Ossifying fibroma (OF) is a rare benign fibro-osseous neoplasm developing mostly in maxillo-facial bones. OF is divided in cemento-ossifying fibroma (COF), juvenile trabecular ossifying fibroma (JTOF) and psammomatoid ossifying fibroma (PSOF). The aim of this systematic review was to synthetize the existing literature on OF, investigating the clinical and radiological parameters related to the different forms of the disease, and to compare the treatment modalities according to their associated recurrence rate.

View Article and Find Full Text PDF

Maxillofacial Bone Involvement in Fibro-Osseous Lesions: Emphasizing the Significance of Differential Diagnosis.

J Clin Med

May 2024

Maxillofacial Surgery Unit, Department of Mental Health and Sense Organs, Santa Maria Le Scotte, University Hospital of Siena, Viale Mario Bracci, 16, 53100 Siena, Italy.

Article Synopsis
  • The World Health Organization's 2022 update has transformed the diagnosis and treatment of odontogenic and maxillofacial bone tumors by incorporating new molecular insights.
  • Fibro-osseous lesions include various types like fibrous dysplasia and Ossifying Fibromas, which, while histologically similar, differ in clinical effects and prognosis, making accurate diagnosis essential.
  • The text discusses two specific cases—fibrous dysplasia and Cemento-Ossifying Fibroma—highlighting their diagnoses, clinical experiences, and management approaches, while ensuring ethical considerations were met.
View Article and Find Full Text PDF

Juvenile ossifying fibroma of maxilla: Concurrent presentation of psammomatoid and trabecular variant.

J Oral Maxillofac Pathol

December 2023

Department of Oral Pathology and Microbiology, Meenakshi Ammal Dental College, Meenakshi Academy of Higher Education and Research, Chennai, Tamil Nadu, India.

Juvenile Ossifying Fibroma (JOF) is a type of ossifying fibroma which occurs in younger individuals and manifests as trabecular and psammomatoid variants. The nature and behaviour of these variants vary, and they exhibit characteristic histopathological appearance. The solitary presentation of these subtypes is reported in numbers, but co-occurrence of both these entities is very few.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!